(Q38543994)

4 September 2017

1 reference

title

Acetazolamide for the treatment of idiopathic intracranial hypertension (English)

1 reference

4 September 2017

1 reference

1

Claudiu T Supuran

1 reference

4 September 2017

publication date

7 July 2015

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

4 September 2017

published in

1 reference

4 September 2017

volume

15

1 reference

4 September 2017

issue

8

1 reference

4 September 2017

page(s)

851-856

1 reference

Mechanism of action of acetazolamide and idiopathic intracranial hypertension

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Idiopathic intracranial hypertension in the Middle East: A growing concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Structure-based drug discovery of carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Interfering with pH regulation in tumours as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Sulfonamides: a patent review (2008 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Secondary and tertiary sulfonamides: a patent review (2008 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Novel therapies for glaucoma: a patent review 2007 - 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Antiglaucoma carbonic anhydrase inhibitors: a patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Antiobesity carbonic anhydrase inhibitors: a literature and patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic anhydrase inhibitors as anticonvulsant agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Molecular mechanisms of cerebrospinal fluid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

A comparative approach to carbonic anhydrase: the work of Thomas H. Maren

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Chloride efflux from isolated choroid plexus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

The kinetics of HCO3- synthesis related to fluid secretion, pH control, and CO2 elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Safety of carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

α-Carbonic anhydrases are sulfatases with cyclic diol monosulfate esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Structural Insights on Carbonic Anhydrase Inhibitory Action, Isoform Selectivity, and Potency of Sulfonamides and Coumarins Incorporating Arylsulfonylureido Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic anhydrase inhibitors and activators and their use in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic anhydrase inhibitors — Part 29 1: Interaction of isozymes I, II and IV with benzolamide-like derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

Carbonic Anhydrase Inhibitors: Clash with Ala65 as a Means for Designing Inhibitors with Low Affinity for the Ubiquitous Isozyme II, Exemplified by the Crystal Structure of the Topiramate Sulfamide Analogue†

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1066675

10.1586/14737175.2015.1066675

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference